Stay updated on Autologous LN-145 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.

Latest updates to the Autologous LN-145 in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new trial locations and the removal of outdated study details related to a previous phase 2 study of LN-145 for metastatic non-small-cell lung cancer. The current study now includes 60 locations and has updated recruitment information.SummaryDifference24%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Autologous LN-145 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.